← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 1999Last known activity
Apr 2, 2024
Timeline
1990s
- Jun 1, 1990
Nektar Therapeutics— Founded
Drugs by trial phase (42 distinct, 56 trials)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Studied for
- Astrocytoma
- Back Pain
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Transitional Cell
- Chronic Pain
- Colorectal Neoplasms
- Communicable Diseases
- Constipation
- Coronavirus Infections
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Glioblastoma
- Headache
- Healthcare-Associated Pneumonia
- Infections
- Liver Diseases
- Low Back Pain
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, Non-Hodgkin
- Melanoma
- Migraine Disorders
- Migraine with Aura
- Migraine without Aura
- Multiple Myeloma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Oligodendroglioma
- Osteoarthritis
- Osteoarthritis, Knee
- Ovarian Neoplasms
- Pneumonia
- Pneumonia, Bacterial
- Pneumonia, Ventilator-Associated
- Prostatic Neoplasms
- Psoriasis
- Recurrence
- Respiratory Tract Infections
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
Recent trials (50)
- NCT06340360Lead sponsorPhase 2Apr 2, 2024
- NCT06340360OfficialPhase 2Apr 2, 2024
- NCT05676749CollaboratorPhase 1Dec 31, 2023
- NCT06136741Lead sponsorPhase 2Oct 23, 2023
- NCT06136741Study directorPhase 2Oct 23, 2023
- NCT05632809CollaboratorPhase 2Apr 30, 2023
- NCT05664217Lead sponsorPhase 2/Phase 3Dec 31, 2022
- NCT05664217Study directorPhase 2/Phase 3Dec 31, 2022
- NCT05359211CollaboratorPhase 1Dec 28, 2022
- NCT05565729Study directorPhase 1Oct 5, 2022
- NCT05565729Lead sponsorPhase 1Oct 5, 2022
- NCT04969861Lead sponsorPhase 2/Phase 3Oct 31, 2021
- NCT04969861Study directorPhase 2/Phase 3Oct 31, 2021
- NCT04936841CollaboratorPhase 2Aug 5, 2021
- NCT04730349CollaboratorPhase 1/Phase 2Apr 15, 2021
Details
- Founded
- San Carlos, CA, US Jun 1, 1990
- Last known activity
- Apr 2, 2024